Comparative In Vitro Activity of New Beta-Lactam Antibiotics Against Anaerobic Bacteria (Q39856001)

15 September 2017

Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.20.5.600

15 September 2017

Comparative In Vitro Activity of New Beta-Lactam Antibiotics Against Anaerobic Bacteria (English)

1 reference

6 May 2024

0 references

2

Finegold SM

1 reference

15 September 2017

R. D. Rolfe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7325628

6 May 2024

language of work or name

English

0 references

publication date

1 November 1981

1 reference

full work available at URL

15 September 2017

https://europepmc.org/articles/pmc181759?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7325628

https://europepmc.org/articles/PMC181759

6 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7325628

https://europepmc.org/articles/PMC181759?pdf=render

6 May 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7325628

https://journals.asm.org/doi/pdf/10.1128/AAC.20.5.600

6 May 2024

1 reference

https://api.crossref.org/works/10.1128/AAC.20.5.600

Antimicrobial Agents and Chemotherapy

6 May 2024

published in

1 reference

15 September 2017

20

1 reference

15 September 2017

5

1 reference

15 September 2017

600-609

1 reference

Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Metronidazole versus anaerobes. In vitro data and initial clinical observations

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Beta-lactamase activity in anaerobic bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

In vitro activity of thienamycin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Inactivation of Cephalosporins by Bacteroides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

In vitro activity of LY127935.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic Bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

In Vitro Activity of Cefoxitin and Parenterally Administered Cephalosporins against Anaerobic Bacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Activity of HR 756 against Haemophilus influenzae, Barteroides fragilis and Gram-negative rods

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Unique Bactericidal Action of Metronidazole Against Bacteroides fragilis and Clostridium perfringens

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and Cefoxitin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Beta-Lactamase Activity in Strains of Bacteroides melaninogenicus and Bacteroides oralis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Susceptibility of anaerobic bacteria to 23 antimicrobial agents

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Characterisation of a -Lactamase Obtained from a Strain of Bacteroides Fragilis Resistant to -Lactam Antibiotics

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

In Vitro Activity of LY127935

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

<i>In vitro</i> Comparison of Three New Cephalosporins: LY-127935, Cefotaxime and Cefoperazone

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=181759

Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7325628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7325628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bacteroides fragilis resistant to the administration of clindamycin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7325628

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.20.5.600

1 reference

15 September 2017

1 reference

15 September 2017

1 reference